Challenges

One of the more recent health phenomena of the last few years has been gut health and the benefits of maintaining our microbiome. Admittedly, it...

Glioblastoma multiforme (GBM) is one of the most common and difficult-to-treat adult brain tumors. With an estimated 10,000 new US diagnoses per...

We sat down with Meaghan Loy, Category Director, In Vivo Services at Scientist.com, to discuss her perspective on clinical trials and to learn more...

It’s now well known that biopharmaceutical companies are increasingly turning to third-party suppliers to support their research and development...

Meaghan Loy, Category Director of In Vivo Services at Scientist.com and member of the North American 3Rs Collaborative Board of Directors...

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

Biotechnology companies aim to develop products and technologies that can solve the many health-related problems that plague our world today. The...

By Maria Menikou, Category Director, Human Biological Samples at Scientist.com and Gina Dunne Smith, Executive Director at International Institute...

Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within...

The first occurrence of human infections of the novel Coronavirus (COVID-19) was recognized in Wuhan, China. Due to its fast spreading and...